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Weiser et al.[1] estimated the global number of 
patients undergoing surgery in 2004 to be over 234 
million, with 0.5% of these patients dying during or 
shortly after their surgical procedure. These alarming 
statistics emphasise the importance of surgical safety 
and the need to identify risk factors associated with in-hospital 
mortality (IHM) in patients before their surgery, so that these 
risk factors may be appropriately managed to reduce the risk of 
perioperative IHM. Studies of perioperative mortality have been 
confined primarily to European[2] and North American[3] surgical popu-
lations. Interestingly, the clinical importance of comorbi dities in the 
pathology of adverse outcomes may differ between South African 
(SA) patients and patients from Europe and North America.[4] The 
current epidemiological transition towards a higher burden of 
non-communicable disease in SA patients appears to explain these 
observed differences.[4,5] For example, while hypertension has been 
associated with an almost four-fold increased risk of postoperative 
mortality in SA non-cardiac vascular surgery patients,[5] similar 
research by a vascular surgery research group in New England, USA, 
did not identify hypertension as a predictor of adverse perioperative 
events.[6] It is therefore imperative that SA non-cardiac patients 
be stratified for perioperative risk through a country-specific list 
of appropriate comorbid risk factors. We sought to determine the 
relationship between several common comorbid conditions and IHM 
in a cohort of SA non-cardiac surgery patients.
Methods
This study was conducted at Inkosi Albert Luthuli Central 
Hospi tal (IALCH), Durban, SA. The hospital provides a tertiary 
service to patients living in the province of KwaZulu-Natal. 
Ethical approval was obtained from the Biomedical Research 
Ethics Committee of the University of KwaZulu-Natal before 
commencing the study. The hospital’s administrative database 
was used to identify all patients aged ≥45 years who underwent 
elective non-cardiac surgery at the hospital between 2005 and 
2012. International Statistical Classification of Diseases and Related 
Health Problems (10th edition) (ICD-10) codes were then used 
to extract data related to comorbidities from patient electronic 
medical records and create a database for statistical analysis. We 
used an age of ≥45 years as an inclusion criterion for this study, in 
keeping with other large studies of perioperative outcomes.[7] The 
effects of the following comorbidities on IHM were investigated: 
hypertension, diabetes, renal dysfunction, ischaemic heart disease, 
congestive heart failure and cerebrovascular disease/stroke. 
Hypertension was included because it is highly prevalent in the SA 
surgical population.[5] The other five comorbidities are established 
risk factors for poor perioperative outcomes and form part of Lee’s 
Revised Cardiac Risk Index (RCRI),[8] which is commonly used 
as a perioperative risk stratification tool at IALCH. In-hospital 
death was determined by evaluating each patient’s discharge record 
following their surgery. Vascular surgery, thoracic surgery and 
general surgery were classified as high-risk surgical specialties.[2] 
Duplicate records, patients aged <45 years, cardiac surgery patients 
and non-surgical patients were excluded from the final data set. 
Categorical data were analysed using the χ2 test or Fisher’s exact 
test, where appropriate. Binary logistic regression was used to 
identify independent associations between comorbidities and 
IHM. A result was considered statistically significant at a p-value 
of <0.05. Results for the logistic regression analysis are presented 
as odds ratios (ORs) with 95% confidence intervals (CIs). The 
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population-attributable fraction (PAF) 
for each factor independently associated 
with a higher incidence of IHM was also 
calculated.[9] Univariate and multivariate 
statistical analyses were performed using 
the Statistical Package for the Social 
Sciences (SPSS) version 21 (SPSS Inc., 
USA).
Results
The final study cohort comprised 3 727 
non-cardiac surgery patients. Reasons for 
excluding patients from the final data set 
are shown in Fig. 1. Overall, the cumulative 
incidence of IHM in this study was 7.5%. 
Table 1 shows the proportion of patients in 
the final study cohort by surgical specialty. 
Almost half of all patients underwent surgery 
that fell within a high-risk surgical specialty 
group. Renal surgery and vascular surgery 
were the surgical specialties associated with 
the highest levels of IHM (incidences of 
24.3% and 7.0%, respectively).
The preoperative clinical characteristics 
of the study cohort are shown in Table 2. 
There was a high prevalence of diabetes and 
hypertension in the cohort (46.7% and 79.1%, 
respectively). Statistically significant univariate 
associations were observed between IHM and 
male gender (p<0.001), elderly age (p<0.001), 
diabetes (p<0.001), cerebrovascular disease 
(p=0.007) and renal dysfunction (p<0.001) 
(Table 2).
Three comorbid conditions (renal 
dys function, congestive heart failure 
and cerebrovascular disease) were inde-
pendently associated with an increased 
risk of IHM following non-cardiac surgery 
(Table  3). In addition, male gender and 
high-risk surgical specialties were also 
independently associated with an increased 
risk of IHM in this study (Table 3).
The results of the PAF analysis for each 
predictor of IHM are shown in Table 4. Renal 
dysfunction had the largest contribution to 
IHM in this study (PAF 0.34), followed by 
7 646 adult patients admitted for
cardiac and non-cardiac procedures
registered on hospital
administrative database
(2005 - 2012)
6 882 patients ≥45 years old
undergoing cardiac and
non-cardiac procedures
3 727 patients ≥45 years old
undergoing non-cardiac
procedures transferred 
postoperatively to surgical wards
Excluded patients:
(i) 598 duplicates
(ii) 166 patients aged <45 years
Excluded patients:
(ii)  1 727 patients undergoing
       cardiac procedures
(iv) 1 428 patients transferred
       postoperatively to medical/
       non-surgical wards
Fig. 1. Study profile.
Table 1. Proportion of patients in the final study cohort by surgical specialty
Surgical specialty n (% of final study cohort)
Gynaecological surgery 130 (3.5)
General surgery 481 (12.9)
Vascular surgery 1 164 (31.2)
Plastic surgery 91 (2.4)
Orthopaedic surgery 321 (8.6)
Urological surgery 370 (9.9)
Ear, nose and throat surgery 96 (2.6)
Renal surgery 494 (13.3)
Thoracic surgery 162 (4.4)
Ophthalmological surgery 418 (11.2)
Total 3 727 (100.0)
Table 2. Baseline patient clinical characteristics expressed as a frequency (%)
Patient characteristic
Total cohort
(N=3 727)
n (%)
Patients with 
in-hospital mortality
(N=278)
n (%)
Patients without 
in-hospital mortality
(N=3 449)
n (%) p-value*
Male gender 1 591 (42.7) 150 (54.0) 1 441 (41.8) <0.001
Age >65 years 1 265 (33.9) 65 (23.4) 1 200 (34.8) <0.001
Ischaemic heart disease 420 (11.3) 23 (8.3) 397 (11.5) 0.101
Diabetes 1 739 (46.7) 98 (35.3) 1 641 (47.6) <0.001
Congestive heart failure 50 (1.3) 7 (2.5) 43 (1.2) 0.095
Renal dysfunction 487 (13.1) 119 (42.8) 368 (10.7) <0.001
Cerebrovascular disease/stroke 87 (2.3) 13 (4.7) 74 (2.1) 0.007
Hypertension 2 948 (79.1) 209 (75.2) 2 739 (79.4) 0.095
High-risk surgical specialty 1 807 (48.5) 125 (45.0) 1 682 (48.8) 0.222
*p<0.05 was considered statistically significant.
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high-risk surgery (PAF 0.15), male gender 
(PAF 0.08), cerebrovascular disease (PAF 
0.03) and congestive heart failure (PAF 0.03).
Discussion
The incidence of postoperative IHM in our 
study was much higher than that reported 
for most Nothern and Western European 
countries.[10] This may be explained in part by 
the fact that almost half our patient population 
underwent surgery in a high-risk specialty, 
placing them at increased risk of IHM after the 
procedures.
We found univariate associations between 
increased IHM and male gender, age >65 years, 
diabetes, renal dysfunction, cerebrovascular 
disease and high-risk surgery. Interestingly, 
while our observation that renal dysfunction and 
cerebrovascular disease were more common in 
patients who died in hospital was in agreement 
with the studies of Pearse et al.,[10] Charlson et 
al.[11] and Elixhauser et al.,[12] our observation 
that diabetes was significantly more common in 
patients who did not suffer IHM was in contrast 
to the findings of these studies.
Following multivariate statistical analysis, 
male gender, renal dysfunction, congestive 
heart failure, cerebrovascular disease and 
high-risk surgical specialties were identified 
as independent predictors of IHM in SA 
non-cardiac surgery patients. While the 
importance of renal dysfunction has been 
described in overseas surgical populations, 
its contribution to IHM in SA non-cardiac 
surgery patients is of concern, with just over 
one-third of the risk associated with IHM 
being attributed to renal dysfunction.
Waikar et al.[13] found that although 
IHM rates among patients with acute renal 
dysfunction had decreased between 1988 
and 2002, mortality rates for patients not 
requiring dialysis and those requiring dialysis 
were >20% and >30%, respectively. In the 
perioperative setting, a serum creatinine level 
of >177 µmol/L has previously been shown to 
be an independent predictor of perioperative 
cardiovascular morbidity and mortality in 
non-cardiac surgery patients.[8] ‘Renal disease’ 
and ‘renal failure’ were also associated with 
IHM in the studies of Charlson et al.[11] and 
Elixhauser et al.,[12] respectively.
In addition to the risk stratification studies 
of Charlson et al.[11] and Elixhauser et al.,[12] 
congestive heart failure was also identified as 
an independent predictor of cardiovascular 
morbidity and mortality in patients undergoing 
non-cardiac surgery by Lee et al.,[8] as well 
as in the validation study of Lee’s RCRI.[14] 
Hernandez et al.[15] observed substantial levels 
of morbidity and mortality in older patients 
with congestive heart failure who underwent 
non-cardiac surgery. Similarly, Hammill et 
al.[16] found that patients with heart failure were 
at higher risk of operative mortality than those 
without (adjusted OR 1.63; 95% CI 1.52 - 1.74).
It is estimated that up to 14% of patients 
with a first-time stroke may have stroke 
recurrence within a year.[17] Patients with 
recurrent stroke have a higher mortality 
rate than those with a first-time stroke,[18] 
with surgery and its associated physiological 
stresses likely to increase the risk of mortality. 
The findings of this study are once again in 
agreement with the studies by Lee et al.[8] and 
Charlson et al.,[11] who observed a higher risk 
of perioperative mortality in patients with a 
history of cerebrovascular disease.
High-risk surgical specialties were also 
found to be associated with an increased risk 
of IHM in our study, which is in agreement 
with a large database study of 3.7 million 
surgical procedures conducted in 102 Dutch 
hospitals by Noordzij et al.[2]
We did not find ischaemic heart disease, 
diabetes or hypertension to be inde pendently 
associated with IHM in this study. It is likely 
that these comorbidities were under-diagnosed 
in our non-cardiac surgery population, in 
particular in the group of patients who suffered 
IHM. The problem of under-diagnosis of 
comorbidities has been established by a number 
of studies,[19-21] although the reasons for under-
diagnosis, as in our study, remain unclear. In 
addition, we did not observe elderly age to be 
an independent predictor of IHM following 
non-cardiac surgery in SA patients, although 
this finding may be related to the fact that only a 
third of our cohort was >65 years old.
Study limitations
This study was not without limitations. The 
identification of co morbidities in this study was 
based on a physician’s diagnosis at admission 
and the subsequent coding of this diagnosis 
on the hospi tal administrative database. As 
such, we were unable to measure the extent of 
undiagnosed comorbidity in our study, which 
is likely to be an important determinant of the 
findings for ischaemic heart disease, diabetes 
and hypertension. Also, the admini strative 
database was limited by the accuracy with 
which perioperative medication was recorded; 
we were therefore unable to investigate the 
impact of medication use on IHM following 
non-cardiac surgery. A prospectively designed 
study that includes appropriate measures 
to diagnose patient comorbidity, as well as 
perioperative medication use, is required.
Conclusion
The incidence of IHM following non-cardiac 
surgery in our study was much higher than that 
reported for several developed-world European 
countries. This finding highlights the importance 
of identifying independent predictors of IHM in 
non-cardiac surgery patients, so that attempts 
can be made to optimise a patient’s condition 
prior to their surgery and reduce their risk of 
postoperative IHM.
Adequate preoperative management of 
renal dysfunction, congestive heart failure and 
cerebrovascular disease may improve outcome 
after surgery. It is likely that ischaemic heart 
disease, diabetes and hypertension are under-
diagnosed in SA non-cardiac surgery patients. 
Further prospectively designed research is 
required to confirm our findings.
Table 3. Results of multivariate analysis: clinical variables independently associated/
not independently associated with IHM
Clinical variable OR (95% CI) p-value*
Male gender 1.433 (1.107 - 1.853) 0.006
Age >65 years 0.840 (0.616 - 1.147) 0.273
Ischaemic heart disease 0.815 (0.515 - 1.290) 0.383
Diabetes 0.832 (0.634 - 1.092) 0.185
Congestive heart failure 2.604 (1.119 - 6.060) 0.026
Renal dysfunction 7.585 (5.480 - 10.50) <0.001
Cerebrovascular disease/stroke 2.645 (1.414 - 4.950) 0.002
Hypertension 1.119 (0.823 - 1.522) 0.474
High-risk surgical specialty 1.646 (1.213 - 2.233) <0.001
*p<0.05 was considered statistically significant.
Table 4. PAFs for clinical variables 
associated with IHM in SA non-cardiac 
surgery patients
Comorbidity PAF
Congestive heart failure 0.03
Renal dysfunction 0.34
Cerebrovascular disease/stroke 0.03
High-risk surgical specialty 0.15
Male gender 0.08
RESEARCH
129       February 2015, Vol. 105, No. 2
Acknowledgements. This work forms a component of the doctoral studies 
of Y Moodley, who is the recipient of a doctoral scholarship awarded by 
the South African National Research Foundation.
Referencew
1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: 
A modelling strategy based on available data. Lancet 2008;372(9633):139-144. [http://dx.doi.
org/10.1016/S0140-6736(08)60878-8]
2. Noordzij PG, Poldermans D, Schouten O, Bax JJ, Schreiner FA, Boersma E. Postoperative mortality 
in The Netherlands: A population-based analysis of surgery-specific risk in adults. Anesthesiology 
2010;112(5):1105-1115. [http://dx.doi.org/10.1097/ALN.0b013e3181d5f95c]
3. Barnett S, Moonesinghe SR. Clinical risk scores to guide perioperative management. Postgrad Med J 
2011;87(1030):535-541. [http://dx.doi.org/10.1136/pgmj.2010.107169]
4. Steyn K, Sliwa K, Hawken S, et al. Risk factors associated with myocardial infarction in Africa: The 
INTERHEART Africa study. Circulation 2005;112(23):3554-3561. [http://dx.doi.org/10.1161/
CIRCULATIONAHA.105.563452]
5. Biccard BM, Nepaul S. Risk factors associated with intermediate and long-term mortality following vascular 
surgery in South African patients. Cardiovasc J Afr 2010;21(5):263-267. [http://dx.doi.org/CVJ-21.004]
6. Bertges DJ, Goodney PP, Zhao Y, et al. The Vascular Study Group of New England Cardiac Risk Index 
(VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in 
vascular surgery patients. J Vasc Surg 2010;52(3):674-683. [http://dx.doi.org/10.1016/j.jvs.2010.03.031]
7. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels 
and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012;307(21):2295-2304. 
[http://dx.doi.org/10.1001/jama.2012.5502]
8. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple
index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100(10):1043-1049. 
[http://dx.doi.org/10.1161/01.CIR.100.10.1043]
9. Steenland K, Armstrong B. An overview of methods for calculating the burden of disease
due to specific risk factors. Epidemiology 2006;17(5):512-519. [http://dx.doi.org/10.1097/01.
ede.0000229155.05644.43]
10. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: A 7 day cohort study. Lancet 
2012;380(9847):1059-1065. [http://dx.doi.org/10.1016/S0140-6736(12)61148-9]
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity 
in longitudinal studies: Development and validation. J Chronic Dis 1987;40(5):373-383. [http://dx.doi.
org/10.1016/0021-9681(87)90171-8]
12. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative 
data. Med Care 1998;36(1):8-27.
13. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal
failure, 1988 to 2002. J Am Soc Nephrol 2006;17(4):1143-1150. [http://dx.doi.org/10.1681/ASN.2005091017]
14. Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac
surgery: Validation of the Lee cardiac risk index. Am J Med 2005;118(10):1134-1141. [http://dx.doi.
org/10.1016/j.amjmed.2005.01.064]
15. Hernandez AF, Whellan DJ, Stroud S, Sun JL, O’Connor CM, Jollis JG. Outcomes in heart failure
patients after major noncardiac surgery. J Am Coll Cardiol 2004;44(7):1446-1453. [http://dx.doi.
org/10.1016/j.jacc.2004.06.059]
16. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major 
noncardiac surgery. Anesthesiology 2008;108(4):559-567. [http://dx.doi.org/10.1097/ALN.0b013e31816725ef]
17. Dickerson LM, Carek PJ, Quattlebaum RG. Prevention of recurrent ischemic stroke. Am Fam
Physician 2007;76(3):382-388.
18. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: Predictors, severity, 
and prognosis. The Copenhagen Stroke Study. Neurology 1997;48(4):891-895. [http://dx.doi.
org/10.1212/WNL.48.4.891]
19. Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G. Social deprivation and statin prescribing: 
A cross-sectional analysis using data from the new UK general practitioner ‘Quality and Outcomes 
Framework’. J Public Health (Oxf) 2007;29(1):40-47. [http://dx.doi.org/10.1093/pubmed/fdl068]
20. Soljak M, Samarasundera E, Indulkar T, Walford H, Majeed A. Variations in cardiovascular disease 
under-diagnosis in England: National cross-sectional spatial analysis. BMC Cardiovasc Disord
2011;11:12. [http://dx.doi.org/10.1186/1471-2261-11-12]
21. Ward PR, Noyce PR, St Leger AS. Are GP practice prescribing rates for coronary heart disease drugs 
equitable? A cross sectional analysis in four primary care trusts in England. J Epidemiol Community 
Health 2004;58(2):89-96. [http://dx.doi.org/10.1136/jech.58.2.89]
Accepted 9 December 2014.
